<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>House Church Network | Little Robb | Activity</title>
	<link>http://city-refuge.org/housechurch/members/pushyew84/activity/</link>
	<atom:link href="http://city-refuge.org/housechurch/members/pushyew84/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Little Robb.</description>
	<lastBuildDate>Tue, 16 Dec 2025 20:45:54 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b1eb0b13450a2802da1e6440d7400caa</guid>
				<title>Little Robb posted an update: All of us collected information for those interventional most [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/17795/</link>
				<pubDate>Thu, 02 Nov 2023 08:07:18 +0000</pubDate>

									<content:encoded><![CDATA[<p>All of us collected information for those interventional most cancers many studies coming from ClinicalTrials.gov as well as used google&#8217;s Fog up Health-related Normal Language Program Programming User interface (API) to investigate clinical trial Name and Qualifications Criteria text message. An informatics direction leverage interoperability&hellip;<span class="activity-read-more" id="activity-read-more-17795"><a href="http://city-refuge.org/housechurch/activity/p/17795/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c4ffcfb07f9dc004654a6fc9d58ee26a</guid>
				<title>Little Robb posted an update: In addition, JNJ-1013 potently inhibited IRAK1 downstream [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/12681/</link>
				<pubDate>Wed, 01 Nov 2023 08:17:08 +0000</pubDate>

									<content:encoded><![CDATA[<p>In addition, JNJ-1013 potently inhibited IRAK1 downstream signaling paths along with proven powerful anti-proliferative effects inside ABC DLBCL tissues using MyD88 mutation. The project shows that IRAK1 degraders potentially have for the treatment malignancies that are dependent on your IRAK1 scaffolding perform.Recently, semiconductor-based&hellip;<span class="activity-read-more" id="activity-read-more-12681"><a href="http://city-refuge.org/housechurch/activity/p/12681/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3b6548f91f27b0e041a4b7879a1f34d6</guid>
				<title>Little Robb posted an update: The particular identified suicidal risks is analytic [&#133;]</title>
				<link>http://city-refuge.org/housechurch/activity/p/7939/</link>
				<pubDate>Tue, 31 Oct 2023 08:13:47 +0000</pubDate>

									<content:encoded><![CDATA[<p>The particular identified suicidal risks is analytic standards with regard to differential diagnostiThe objective ended up being figure out specialized medical as well as genealogy along with pathophysiological guns with the chance recurrent depression improvement risk. Medical and also psychopathological, ancestry and genealogy, psychometric&hellip;<span class="activity-read-more" id="activity-read-more-7939"><a href="http://city-refuge.org/housechurch/activity/p/7939/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1cdba9233277fb2cbba0e07eedce6292</guid>
				<title>Little Robb became a registered member</title>
				<link>http://city-refuge.org/housechurch/activity/p/7023/</link>
				<pubDate>Tue, 31 Oct 2023 01:04:11 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>